ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,835Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 298

$442K Total Retail Price of All Prescriptions

Rank: 44 out of 298

246 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 246 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 246 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,135 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
FUROSEMIDE 268 215 1 5
LEVOTHYROXINE SODIUM 223 181 2 1
OMEPRAZOLE 210 158 3 3
SIMVASTATIN 182 157 4 2
LISINOPRIL 150 120 5 4
AMLODIPINE BESYLATE 149 149 6 6
CITALOPRAM HBR 143 122 7 17
GABAPENTIN 117 80 8 20
METOPROLOL SUCCINATE 116 101 9 12
POTASSIUM CHLORIDE 114 93 10 11
HYDROCODONE-ACETAMINOPHEN 113 83 S3 11 8
TRAMADOL HCL 109 100 12 15
SPIRONOLACTONE 108 95 13 34
METOPROLOL TARTRATE 104 60 14 9
CARVEDILOL 90 78 15 23
ATENOLOL 89 62 16 16
SYNTHROID 89 67 16 42
PREDNISONE 89 80 16 33
HYDROCHLOROTHIAZIDE 87 52 19 13
METFORMIN HCL 82 57 20 10
KLOR-CON M20 82 80 20 78
CLOPIDOGREL 78 56 22 36
NEXIUM 76 72 23 40
ATORVASTATIN CALCIUM 74 47 24 14
LOSARTAN POTASSIUM 74 52 24 18
LANTUS 73 60 26 53
WARFARIN SODIUM 71 71 27 7
DONEPEZIL HCL 69 66 28 22
FENTANYL 63 52 S2 29 32
OXYCONTIN 63 15 S2 29 162
POLYETHYLENE GLYCOL 3350 59 56 31 29
NOVOLIN R 58 32 32 195
FAMOTIDINE 54 54 33 80
BENAZEPRIL HCL 54 43 33 52
COUMADIN 52 28 35 182
SERTRALINE HCL 52 22 35 19
MIRTAZAPINE 51 45 37 37
AMITRIPTYLINE HCL 50 22 R 38 51
ZOLPIDEM TARTRATE 50 38 38 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.